Implantable Hearing Devices

Implantable Hearing Devices

Implantable Hearing Devices

On this page

Overview & Classification - Hearing Helpers Within

  • Surgically implanted electronic devices; manage hearing loss when conventional hearing aids are insufficient or contraindicated.
  • Major Categories:
    • Bone Conduction Devices (BCDs/BAHAs): Transmit sound via bone vibration. For conductive/mixed hearing loss (HL), single-sided deafness (SSD).
    • Middle Ear Implants (MEIs): Directly drive ossicles or cochlear windows. For sensorineural/mixed HL.
    • Cochlear Implants (CIs): Electrically stimulate auditory nerve. For severe-profound SNHL.
    • Auditory Brainstem Implants (ABIs): Stimulate cochlear nucleus. For cochlear nerve aplasia/Neurofibromatosis type 2 (NF2).

⭐ Cochlear Implants bypass damaged hair cells to directly stimulate spiral ganglion neurons, offering hearing to those with severe-to-profound sensorineural hearing loss (SNHL).

Cochlear Implants (CI) - Sounding Out Success

Cochlear Implant Components and Placement

  • Principle: Bypasses damaged/absent cochlear hair cells; provides direct electrical stimulation to auditory nerve fibers.
  • Components:
    • External: Microphone, speech processor, transmitting coil.
    • Internal: Receiver-stimulator package, electrode array (inserted into scala tympani of cochlea).
  • Key Candidacy Criteria:
    • Bilateral severe-to-profound SNHL.
    • Limited benefit from appropriately fitted hearing aids (e.g., sentence recognition < 50% in ear to be implanted, < 60% bilaterally).
    • No medical contraindications; realistic expectations.
  • Sound Pathway:

⭐ The electrode array of a CI is typically inserted into the scala tympani of the cochlea to stimulate different frequency regions along the basilar membrane.

Bone Conduction Devices - Bone-Deep Beats

Bone Anchored Hearing Aid (BAHA) Diagram

  • Bypass outer/middle ear, directly stimulate cochlea via bone vibration.
  • Indications:
    • Conductive Hearing Loss (CHL): Chronic otitis media, atresia, ossicular chain disruption.
    • Mixed Hearing Loss (MHL).
    • Single-Sided Deafness (SSD): Transcranial routing of signal.
  • Types:
    • Percutaneous (e.g., BAHA Connect): Abutment through skin.
    • Transcutaneous (e.g., BAHA Attract, Sophono, Bonebridge): Magnet or passive implant under intact skin.
  • Advantages: Good for draining ears, avoids occlusion effect.

⭐ BAHA is FDA-approved for children aged 5 years and older for CHL/MHL, and for SSD.

MEI & ABI - Beyond the Cochlea

  • Middle Ear Implants (MEI):

    • Directly stimulate middle ear structures (ossicles) or round window.
    • For moderate-severe sensorineural hearing loss (SNHL) or conductive/mixed hearing loss.
    • Types: Piezoelectric, electromagnetic.
    • Advantages: No occlusion effect, better sound quality for some.
    • E.g., Vibrant Soundbridge, Esteem.
  • Auditory Brainstem Implants (ABI):

    • Stimulate cochlear nucleus in brainstem.
    • For patients with non-functional cochlear nerves (e.g., bilateral acoustic neuromas like in NF2, cochlear aplasia/hypoplasia, cochlear nerve aplasia, ossified cochleas not suitable for CI).
    • Provides sound awareness, aids lip-reading.

Piezoelectric transducer implant components and placement

⭐ ABI is the treatment of choice for hearing rehabilitation in Neurofibromatosis type 2 (NF2) patients post bilateral vestibular schwannoma surgery where cochlear nerves are not preserved.

Complications & Comparison - Weighing the Wires

  • General Complications:
    • Infection (wound, device), device extrusion/failure.
    • Nerve injury (e.g., facial nerve, chorda tympani).
    • Pain, vertigo, tinnitus, skin flap necrosis.
  • Device Comparison Highlights:
    • CI: For severe-profound SNHL; direct cochlear nerve stimulation.
    • AMEI: SNHL/mixed/conductive; direct ossicular/RW drive.
    • BCD (e.g., BAHA): Conductive/mixed loss, SSD; skull vibration.

⭐ MRI safety is paramount: field strength limits (e.g., 1.5T, 3T), magnet removal/splinting often required. Device failure is a long-term risk.

High‑Yield Points - ⚡ Biggest Takeaways

  • Cochlear Implants (CI): For severe-profound SNHL; directly stimulate auditory nerve.
  • BAHA/BCHA: For CHL, MHL, SSD; utilize bone conduction.
  • Middle Ear Implants (MEI): For moderate-severe SNHL/mixed/conductive loss; vibrate ossicles.
  • Auditory Brainstem Implants (ABI): For absent cochlear nerves (e.g., NF2), cochlear ossification; stimulates cochlear nucleus.
  • EAS (Electro-Acoustic Stimulation): Combines CI (high-freq) & acoustic amplification (low-freq) for partial deafness.
  • CI candidacy: Bilateral profound SNHL, <50% sentence recognition (aided).
  • Risks: Infection, device failure, facial nerve stimulation, CSF leak.

Practice Questions: Implantable Hearing Devices

Test your understanding with these related questions

A female patient presents with hearing loss. Rinne test results show Rinne negative at 256 Hz and 512 Hz, while Rinne positive at 1024 Hz. Based on these findings, what is the expected air conduction and bone conduction gap?

1 of 5

Flashcards: Implantable Hearing Devices

1/10

_____lateral conductive type of hearing loss is seen in otosclerosis

TAP TO REVEAL ANSWER

_____lateral conductive type of hearing loss is seen in otosclerosis

Bi

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial